Novel Approach for Tracheal Resection in Morquio A Syndrome with End-stage Critical Airway Obstruction: A UK Case Series

Author:

Kenth Johnny1ORCID,Maughan Elizabeth2,Butler Colin2,Gabrie Jasleen3,Rouhani Maral2,Silver Benjamin2,Ogunbiy Olumide2,Wilkinson Stuart1,Nandi Reema2,Walker Rober1,Muthialu Nagarajan2,Jones Simon1,Hewitt Richard2,Bruce Iain1

Affiliation:

1. Royal Manchester Children's Hospital

2. Great Ormond Street Hospital NHS Trust: Great Ormond Street Hospital For Children NHS Foundation Trust

3. University College London

Abstract

Abstract Background Mucopolysaccharidosis (MPS) type IVA is a rare lysosomal storage disorder caused by aberrations of the N-acetyl-galactosamine-6-sulfatase (GALNS) enzyme. MPS IVA is associated with a wide gamut of respiratory and airway disorders that manifest in a continuum of severity. In individuals exhibiting severe phenotypic expression, terminal stages of the disease frequently culminate in life-threatening, critical airway obstruction. These manifestations of end-stage disease are engendered by an insidious progression of multi-level airway pathologies, comprising of tracheomalacia, stenosis, tortuosity and 'buckling'. Historically, the management of end-stage airway disease has predominantly leaned towards palliative modalities. However, contemporary literature has posited that the potential benefits of tracheal resection with aortopexy, performed under cardiopulmonary bypass (CPB), may offer a promising therapeutic option. In this context, we report on outcomes from patients undergoing a novel approach to tracheal resection that is combined with manubrial resection, leading to improved airway calibre, obviating the requisition for CPB. Results In this study, seven patients with severe MPS IVA exhibited clinical symptoms and radiological evidence indicative of advanced airway obstruction. All patients had a tracheal resection with a partial upper manubriectomy via transcervical approach, which did not require CPB. The median age was 16 years (range 11–19 years). Postoperatively, significant improvements were seen in forced expiratory volume in 1 second (FEV1), with a mean increase of 0.68 (95% CI: 0.45–0.91; SD: 0.20). Notably, other spirometry variables also showed meaningful improvements, providing evidence of positive treatment effects. Furthermore, there were no major long-term complications, and the procedure resulted in a significant enhancement in patient-reported domains using PedsQL (version 4.0). Conclusions This study represents the largest case series to date, on tracheal resection in patients with severe MPS IVA. Our findings demonstrate the effectiveness of the transcervical approach with partial manubriectomy for improving respiratory function and quality of life for individuals with advanced airway obstruction. Tracheal resection presents a promising treatment modality for severe cases of MPS IVA. Successful outcomes rely on meticulous multidisciplinary assessment, judicious decision-making, and appropriate timing of tracheal surgery. Further research and long-term follow-up studies are warranted to validate the long-term efficacy and safety of this approach.

Publisher

Research Square Platform LLC

Reference26 articles.

1. Respiratory complications of metabolic disease in the paediatric population: A review of presentation, diagnosis and therapeutic options;Broomfield A;Paediatr Respir Rev,2019

2. Jones S, Wynn R, Mucopolysaccharidoses. Clinical features and diagnosis - UpToDate [Internet]. [cited 2018 Sep 1]. Available from: https://www.uptodate.com/contents/mucopolysaccharidoses-clinical-features-and-diagnosis?search=MPS%20IV&source=search_result&selectedTitle=1~15&usage_type=default&display_rank=1#H10.

3. Natural history of Morquio A patient with tracheal obstruction from birth to death;Doherty C;Mol Genet Metab Rep,2018

4. Obstructive airway in Morquio A syndrome, the past, the present and the future;Tomatsu S;Mol Genet Metab,2016

5. Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance;Akyol MU;Orphanet J Rare Dis,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3